Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial

Published:2013-12-09 Issue:5 Volume:24 Page:715-724
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Yamamoto Kazuhiko,Takeuchi Tsutomu,Yamanaka Hisashi,Ishiguro Naoki,Tanaka Yoshiya,Eguchi Katsumi,Watanabe Akira,Origasa Hideki,Shoji Toshiharu,Sakamaki Yoshiharu,van der Heijde Désirée,Miyasaka Nobuyuki,Koike Takao

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/14397595.2013.864224

Reference24 articles.

1. A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

2. Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

3. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

4. Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Up to 3-year results from a postmarketing surveillance study;Modern Rheumatology;2024-03-29

2. Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment;JAMA Network Open;2023-06-30

3. Comparative Efficacy of bDMARDs and tsDMARDs for the Treatment of Rheumatoid arthritis: A Systematic Review and Network Meta-Analysis;International Journal of Biology and Life Sciences;2023-06-01

4. Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post‐hoc analysis of clinical trials;International Journal of Rheumatic Diseases;2023-05-17

5. Structural, nonclinical, and clinical features of ozoralizumab: A novel tumour necrosis factor inhibitor;Modern Rheumatology;2023-04-01